Aytu Biopharma (AYTU) Cash from Operations Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) Cash from Operations Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.45 Mn | -5.27 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.69% |
| Sep 30, 2025 | 40.08% |
| Jun 30, 2025 | 18.73% |
| Mar 31, 2025 | -18.26% |
| Dec 31, 2024 | 19.88% |
| Sep 30, 2024 | 16.82% |
| Jun 30, 2024 | 25.67% |
| Mar 31, 2024 | 40.16% |
| Dec 31, 2023 | 49.96% |
| Sep 30, 2023 | 40.14% |
| Jun 30, 2023 | 32.36% |
| Mar 31, 2023 | 6.51% |
| Dec 31, 2022 | 4.31% |
| Sep 30, 2022 | -16.62% |
| Jun 30, 2022 | -16.76% |
| Mar 31, 2022 | -30.67% |
| Dec 31, 2021 | -25.45% |
| Sep 30, 2021 | 6.55% |
| Jun 30, 2021 | -18.78% |
| Dec 31, 2020 | 3.37% |